Tiny Natural Fighters: New Red Glowing Dots Target Cancer with Iron Reaction

David Palenski
18th January, 2024

Tiny Natural Fighters: New Red Glowing Dots Target Cancer with Iron Reaction
Image Source: © Natural Science News. This image is an artistic rendition.
Carbon-based nanomaterials are increasingly investigated for medical applications, particularly in cancer treatment. Traditional chemotherapy often has significant side effects due to its non-specific targeting of cells. Researchers are exploring new materials that can selectively target and destroy cancer cells while minimizing harm to healthy tissue. One promising area involves the use of carbon dots (CDs) – tiny fluorescent particles with unique properties[2]. A recent study from the University of Miami[1] details the creation and testing of a novel type of carbon dot, created from copper chlorophyllin, termed Chl-D CDs. Chlorophyllin is a naturally occurring compound found in plants, and these new CDs leverage its properties to enhance cancer treatment. The core finding is that these Chl-D CDs can boost the effectiveness of photodynamic therapy (PDT) and chemotherapy when used together. Photodynamic therapy involves using a light-sensitive substance and light to kill cancer cells. However, PDT’s effectiveness can be limited. The University of Miami team discovered that Chl-D CDs can trigger a “Fenton-like reaction”. This reaction produces highly reactive oxygen species (ROS) – molecules that can damage and kill cancer cells. This enhancement of ROS production significantly improves the efficacy of PDT. Furthermore, the researchers linked the chemotherapy drug temozolomide directly to the surface of the Chl-D CDs. This combination allows for a synergistic effect, meaning the combined impact is greater than the sum of their individual effects. The biocompatibility of these CDs was thoroughly tested. Biocompatibility refers to a material’s ability to interact with living systems without causing harmful effects. Tests showed the Chl-D CDs were well-tolerated by immune cells and in animal models, suggesting a low risk of adverse reactions. This builds on previous work demonstrating the generally low toxicity and biocompatibility of carbon dots[2][3]. For example, studies have shown that carbon dots derived from metformin also exhibit low toxicity towards both healthy and cancerous cells[3]. To understand how the Chl-D CDs were killing cancer cells, the researchers performed a proteomic analysis. Proteomics is the large-scale study of proteins, which are the workhorses of cells. This analysis revealed that the Chl-D CDs were disrupting several key proteins involved in oxidative stress management within the cancer cells. Specifically, proteins like aldolase A, aldolase C, aldehyde dehydrogenase 1B1, transaldolase 1, and transketolase were affected. These proteins play crucial roles in cellular metabolism, and their disruption contributes to the cancer cells’ demise. The study highlights that the Fenton-like reaction and subsequent ROS formation are central to this process. Interestingly, the way these CDs interact with cells and the body differs depending on their origin and how they are made. For instance, glucose-derived carbon dots created using hydrothermal carbonization have demonstrated anticancer activity against neuroblastoma cells[4], while microwave-assisted synthesis yields CDs capable of crossing the blood-brain barrier[4]. The Chl-D CDs developed in this study offer a different mechanism – enhancing existing therapies through ROS generation and targeted drug delivery. The ability of carbon dots to cross biological barriers, such as the blood-brain barrier, is also a significant area of research[3][4]. While this study didn’t specifically focus on BBB penetration, the favorable biocompatibility profile of Chl-D CDs suggests potential for future investigations in this area. The researchers believe the unique properties of Chl-D CDs pave the way for safer and more effective combination cancer therapies.

MedicineHealthBiotech

References

Main Study

1) Small Warriors of Nature: Novel Red Emissive Chlorophyllin Carbon Dots Harnessing Fenton-Fueled Ferroptosis for In Vitro and In Vivo Cancer Treatment.

Published 17th January, 2024

https://doi.org/10.1002/smll.202309283

Related Studies

2) Carbon Dots as Promising Tools for Cancer Diagnosis and Therapy.

https://doi.org/10.3390/cancers13091991

3) Metformin derived carbon dots: Highly biocompatible fluorescent nanomaterials as mitochondrial targeting and blood-brain barrier penetrating biomarkers.

https://doi.org/10.1016/j.jcis.2021.02.058

4) Hydrothermal vs microwave nanoarchitechtonics of carbon dots significantly affects the structure, physicochemical properties, and anti-cancer activity against a specific neuroblastoma cell line.

https://doi.org/10.1016/j.jcis.2022.10.010


Related Articles

An unhandled error has occurred. Reload 🗙